A Comprehensive Review on Nutraceuticals as Emerging Neuroprotective Agents in Neurodegenerative Diseases
International Journal of Pharmaceutical Sciences Review and Research · 2026-06 · 86 (6)
DOI: 10.47583/ijpsrr.2026.v86i6.035 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Sciences Review and Research, 2026-06. Verfasst von Vaishnavi S Veer und 3 weiteren Autor:innen.
Abstract (Originalsprache)
A rising global health concern, neurodegenerative diseases (NDDs) like Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), Amyotrophic Lateral Sclerosis (ALS), and Multiple Sclerosis (MS) afflict millions of people, mostly the elderly.Complex, interconnected mechanisms such as oxidative stress, mitochondrial dysfunction, abnormal protein aggregation, neuroinflammation, and excitotoxicity are involved in the pathogenesis of various illnesses.various pathways ultimately result in gradual death of neurons.Despite their partial efficacy, conventional pharmaceutical treatments frequently have negative side effects and are unable to address the complex nature of neurodegeneration.The antioxidant, anti-inflammatory, anti-apoptotic, and metalchelating qualities of nutraceutical bioactive substances obtained from natural food sources have made them promising neuroprotective agents.The neuroprotective mechanisms of important nutraceuticals, such as curcumin, resveratrol, omega-3 fatty acids, vitamin E, B-complex vitamins, Bacopa monnieri, and Centella asiatica, are thoroughly examined in this review.These substances work by altering important signaling pathways such Nrf2/ARE, NF-κB, PI3K/Akt, MAPK, and SIRT1/AMPK.Along with current drawbacks such limited bioavailability, lack of standardization, and insufficient large-scale clinical trials, clinical evidence suggesting their therapeutic potential in neurodegenerative disorders is presented.Additionally discussed are future prospects such as combination therapy, nanoformulations, and individualized dietary plans.As safe, multi-targeted adjunct therapy for the management and prevention of neurodegenerative disorders, nutraceuticals have great potential.
Zitieren
APA
Veer, V. S., Sagare, A. R., Jadhav, P. D., & Yadav, H. S. (2026). A Comprehensive Review on Nutraceuticals as Emerging Neuroprotective Agents in Neurodegenerative Diseases. International Journal of Pharmaceutical Sciences Review and Research, 86(6). https://doi.org/10.47583/ijpsrr.2026.v86i6.035
Vancouver
Veer VS, Sagare AR, Jadhav PD, Yadav HS. A Comprehensive Review on Nutraceuticals as Emerging Neuroprotective Agents in Neurodegenerative Diseases. International Journal of Pharmaceutical Sciences Review and Research. 2026;86(6). doi:10.47583/ijpsrr.2026.v86i6.035
BibTeX
@article{Veer2026,
author = {Veer, Vaishnavi S and Sagare, Abhirup R and Jadhav, Prakash D and Yadav, Harshada S},
title = {A Comprehensive Review on Nutraceuticals as Emerging Neuroprotective Agents in Neurodegenerative Diseases},
journal = {International Journal of Pharmaceutical Sciences Review and Research},
year = {2026},
volume = {86},
number = {6},
doi = {10.47583/ijpsrr.2026.v86i6.035}
}
EUVIMED